CDK4 and breast cancer: Else, in breast cancer models, cells activate autophagy in response to Palbociclib, and blockade of autophagy significantly improved the efficacy of CDK4/6 inhibition in in vitro and in vivo breast cancers models with an intact G1/S transition [126].